Free Trial

Sean Wieland Analyst Performance

Analyst at Piper Sandler

Sean Wieland is a stock analyst at Piper Sandler focused in the medical sector, covering 9 publicly traded companies. Over the past year, Sean Wieland has issued 2 stock ratings, including and buy recommendations. While full access to Sean Wieland's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Sean Wieland's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
26 Last 11 Years
Buy Recommendations
72.00% 18 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy72.0%18 ratings
Hold28.0%7 ratings
Sell0.0%0 ratings

Out of 25 total stock ratings issued by Sean Wieland at Piper Sandler, the majority (72.0%) have been Buy recommendations, followed by 28.0% Hold.

Exchange Coverage

ExchangePercentageCount
NYSE
55.6% of companies on NYSE
5 companies
NASDAQ
33.3% of companies on NASDAQ
3 companies
OTCMKTS
11.1% of companies on OTCMKTS
1 company

Sean Wieland, an analyst at Piper Sandler, currently covers 9 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
66.7%
Services
1 company
11.1%
Computer and Technology
1 company
11.1%
Miscellaneous
1 company
11.1%

Sean Wieland of Piper Sandler specializes in stock coverage within the Medical sector, with additional focus on Services and Computer and Technology companies.

Coverage Industries

IndustryPercentage
MEDICAL INFO SYS
3 companies
33.3%
MEDICAL SERVICES
2 companies
22.2%
MED INSTRUMENTS
1 company
11.1%
SERVICES – COMPUTER PROGRAMMING AND DATA PROCESSING
1 company
11.1%
INTERNET SOFTWARE
1 company
11.1%
HOLDING & OTHER INVESTMENT OFFICES
1 company
11.1%

Sean Wieland's Ratings History at Piper Sandler

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Omnicell, Inc. stock logo
OMCL
Omnicell
8/11/2025Lower Price Target$30.83$55.00Overweight
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
8/11/2025Lower Price Target$20.58$35.00Overweight
Privia Health Group, Inc. stock logo
PRVA
Privia Health Group
2/28/2025Boost Price Target$25.46$40.00Overweight